Annual pharmaceuticals conference
The conference will seek to answer questions such as:
- What happens if there is no new blockbuster?
- Has the recent reliance on blockbusters damaged pharma?
- Is the industry structure preventing the introduction of a better business model?
The Economist's healthcare correspondent, Shereen El Feki, will provide an independent assessment of how the industry is faring, a panel of expert speakers will reveal their future strategies, and the senior audience will discuss and debate issues at the top of the pharmaceutical agenda.For further information, please:
click here(opens in new window)